Noncurrent long-term debt increased 24.9%
Noncurrent long-term debt changed +24.9% from the comparable as-filed period.
$4.0B→$5.0B3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ADP financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities increased 22.5%
Current liabilities changed +22.5% from the comparable as-filed period.
$41.9B→$51.4B3 prior comparisons
Gross margin moved 80 bp higher
Gross margin changed +80 basis points from the comparable as-filed period.
45.20%→46.00%2 prior comparisons
Stockholders' equity decreased 20.1%
Stockholders' equity changed -20.1% from the comparable as-filed period.
$6.4B→$5.1B3 prior comparisons
Revenue increased 6.1%
Revenue changed +6.1% from the comparable as-filed period.
$5.2B→$5.5B2 prior comparisons
Receivables / revenue moved 275 bp lower
Receivables / revenue changed -275 basis points from the comparable as-filed period.
66.93%→64.18%2 prior comparisons
Current assets increased 19.5%
Current assets changed +19.5% from the comparable as-filed period.
$44.2B→$52.8B3 prior comparisons
Net income increased 11.1%
Net income changed +11.1% from the comparable as-filed period.
$1.0B→$1.1B2 prior comparisons
Total assets increased 16.8%
Total assets changed +16.8% from the comparable as-filed period.
$54.3B→$63.5B2 prior comparisons
Working capital / assets moved 188 bp lower
Working capital / assets changed -188 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.18%→2.30%2 prior comparisons
Operating cash flow increased 1.4%
Operating cash flow changed +1.4% from the comparable as-filed period.
$642.3M→$651.0M2 prior comparisons
Operating cash flow / net income decreased 8.8%
Operating cash flow / net income changed -8.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.63→0.582 prior comparisons
Selling, general & administrative increased 5.6%
Selling, general & administrative changed +5.6% from the comparable as-filed period.
$1.0B→$1.1B2 prior comparisons
Cost of revenue increased 4.6%
Cost of revenue changed +4.6% from the comparable as-filed period.
$2.8B→$3.0B2 prior comparisons
Current ratio decreased 2.4%
Current ratio changed -2.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
1.05→1.033 prior comparisons
Operating cash-flow margin moved 55 bp lower
Operating cash-flow margin changed -55 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
12.41%→11.86%2 prior comparisons
Stock-based compensation increased 14.5%
Stock-based compensation changed +14.5% from the comparable as-filed period.
$58.7M→$67.2M2 prior comparisons
Research & development increased 0.0%
Research & development changed +0.0% from the comparable as-filed period.
$251.2M→$251.3M2 prior comparisons
SBC / revenue moved 9 bp higher
SBC / revenue changed +9 basis points from the comparable as-filed period.
1.13%→1.22%2 prior comparisons
R&D / revenue moved 28 bp lower
R&D / revenue changed -28 basis points from the comparable as-filed period.
4.85%→4.58%2 prior comparisons
Trade receivables increased 1.7%
Trade receivables changed +1.7% from the comparable as-filed period.
$3.5B→$3.5B3 prior comparisons
Cash & equivalents increased 20.4%
Cash & equivalents changed +20.4% from the comparable as-filed period.
$2.7B→$3.2B0 prior comparisons
Current assets increased 16.5%
Current assets changed +16.5% from the comparable as-filed period.
$46.5B→$54.2B2 prior comparisons
Operating cash-flow margin moved 1020 bp higher
Operating cash-flow margin changed +1020 basis points from the comparable as-filed period.
27.48%→37.68%0 prior comparisons
Receivables / revenue moved 380 bp lower
Receivables / revenue changed -380 basis points from the comparable as-filed period.
63.89%→60.10%0 prior comparisons
Operating cash flow / net income increased 34.8%
Operating cash flow / net income changed +34.8% from the comparable as-filed period.
1.22→1.650 prior comparisons
Revenue increased 7.0%
Revenue changed +7.0% from the comparable as-filed period.
$5.6B→$5.9B0 prior comparisons
Total assets increased 14.2%
Total assets changed +14.2% from the comparable as-filed period.
$56.4B→$64.5B1 prior comparisons
Gross margin moved 58 bp higher
Gross margin changed +58 basis points from the comparable as-filed period.
47.70%→48.28%0 prior comparisons
Current liabilities increased 13.5%
Current liabilities changed +13.5% from the comparable as-filed period.
$45.8B→$52.0B2 prior comparisons
Working capital / assets moved 221 bp higher
Working capital / assets changed +221 basis points from the comparable as-filed period.
1.22%→3.43%1 prior comparisons
Net income increased 8.8%
Net income changed +8.8% from the comparable as-filed period.
$1.2B→$1.4B0 prior comparisons
Stock-based compensation decreased 18.8%
Stock-based compensation changed -18.8% from the comparable as-filed period.
$62.8M→$51.0M0 prior comparisons
SBC / revenue moved 27 bp lower
SBC / revenue changed -27 basis points from the comparable as-filed period.
1.13%→0.86%0 prior comparisons
Selling, general & administrative increased 6.5%
Selling, general & administrative changed +6.5% from the comparable as-filed period.
$1.0B→$1.1B0 prior comparisons
Cost of revenue increased 5.8%
Cost of revenue changed +5.8% from the comparable as-filed period.
$2.9B→$3.1B0 prior comparisons
Research & development increased 2.8%
Research & development changed +2.8% from the comparable as-filed period.
$247.1M→$253.9M0 prior comparisons
Current ratio increased 2.7%
Current ratio changed +2.7% from the comparable as-filed period.
1.02→1.042 prior comparisons
R&D / revenue moved 17 bp lower
R&D / revenue changed -17 basis points from the comparable as-filed period.
4.45%→4.27%0 prior comparisons
Trade receivables increased 0.6%
Trade receivables changed +0.6% from the comparable as-filed period.
$3.5B→$3.6B2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.